Navigation Links
Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
Date:12/7/2010

When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.

In the case of agricultural areas, excreted antibiotics can then enter stream and river environments through a variety of ways, including discharges from animal feeding operations, fish hatcheries, and nonpoint sources such as the flow from fields where manure or biosolids have been applied. Water filtered through wastewater treatment plants may also contain used antibiotics.

Consequently, these discharges become "potential sources of antibiotic resistance genes," says Amy Pruden, a National Science Foundation CAREER Award recipient, and an assistant professor of civil and environmental engineering at Virginia Tech. http://www.cee.vt.edu/index.php?do=view&content=0&apps=2&level=2&id=17&pid=ea764b3d7ce4e619692fc864f6a5d628

"The presence of antibiotics, even at sub-inhibitory concentrations, can stimulate bacterial metabolism and thus contribute to the selection and maintenance of antibiotic resistance genes," Pruden explains. "Once they are present in rivers, antibiotic resistance genes are capable of being transferred among bacteria, including pathogens, through horizontal gene transfer."

The World Health Organization and the Center for Disease Control recognize antibiotic resistance "as a critical health challenge of our time," Pruden writes in a paper published in a 2010 issue of Environmental Science and Technology.

Pruden says reducing the spread of antibiotic resistance is a critical measure needed to prolong the effectiveness of currently available antibiotics. This is important since "new drug discovery can no longer keep pace with emerging antibiotic-resistant infect
'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study
2. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
3. Virginia Tech graduate student receives first Rachel Carson award for scientific excellence
4. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
5. Virginia Tech biomedical engineering team to study knee ligament sprains
6. Advances in cancer detection research by Virginia Tech engineer featured in British magazine
7. Virginia Tech licenses GenoCAD source code to ISCB
8. Guggenheim fellowship supports research on evolution by Virginia Tech scientist
9. Student research team sequences genome of bacterium discovered in Virginia Tech garden
10. Northrop Grumman Selects Virginia for New Corporate Office
11. Virginia Tech researcher explores role of human behavior in infectious disease emergence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
(Date:8/20/2014)... years, Virginia Tech,s Wu Feng has built upon a ... "Computing in the Cloud" program, and synergistically complemented it ... from the Air Force on "big computing" for mini-drones ... National Institutes of Health on "big data" for the ... computing" aspects from each grant, he was able to ...
(Date:8/20/2014)... of honeybees grows to about 4,000 members, it triggers ... building of a special type of comb used for ... from the Department of Neurobiology and Behaviour at Cornell ... reproductive cycle of honeybee colonies. The results are published ... Nature . , Reproduction isn,t always a honeybee ...
(Date:8/20/2014)...  The second annual Biometrics UnPlugged Executive Summit, ... Florida on September 15, 2014, will ... and Strategy at Samsung, and Philippe de Raet, Vice ... this year,s event is Mobility at the Crossroads ... UnPlugged: Mobility at the Crossroads of Commerce & ...
Breaking Biology News(10 mins):The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Worker bees 'know' when to invest in their reproductive future 2Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2
... created a synthetic protein that, when activated by ultraviolet light, ... arthritis and other serious medical disorders can be detected. ... imaging technology and may someday serve as a way to ... disease have been found. In a study published in the ...
... be changed by a restaurant,s choice of music and lighting, ... a new study., "When we did a makeover of a ... diners to eat 175 fewer calories and enjoy it more," ... and director of Cornell University,s Food and Brand Lab. ...
... Conn., Aug. 29, 2012 /PRNewswire-iReach/ -- The biobanking market presents ... drug and treatment development for specific diseases. The global ... is projected to increase by 30% between 2010 and 2015, ... sector biobanks will experience the greatest increase with growth of ...
Cached Biology News:Collagen-seeking synthetic protein could lead doctors to tumor locations 2Collagen-seeking synthetic protein could lead doctors to tumor locations 3Global Biobanking Market Projected to Increase by 30% to Reach $183 Billion by 2015 2Global Biobanking Market Projected to Increase by 30% to Reach $183 Billion by 2015 3
(Date:8/21/2014)... 21, 2014  Four-dimensional (4-D) printing develops materials ... external stimuli such as changes in temperature. This ... effect in multiple industries.  In the near future, ... printing objects ranging from human organs to parts ... Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
(Date:8/21/2014)... 21, 2014 On Wednesday of last week ... use Redox Signaling molecules, became available for purchase in Australia ... "The way that RENU 28 works is, if you think ... of the rate of cellular renewal within your body. If ... of that rate of cellular renewal. What RENU 28 does ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
Breaking Biology Technology:Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2
... BioSciences Inc.,(AMEX: YMI , TSX: YM, AIM: ... differentiated products for patients worldwide,today announced that clinical ... nimotuzumab, a humanized monoclonal antibody that targets,the epidermal ... American,Society of Clinical Oncology (ASCO) Annual Meeting being ...
... MONTVALE, N.J., June 3 Contemporary ... dedicated to enhancing the surgeon,s,practice, has announced ... tool:,SURGERYFINDIT.COM ( http://www.SURGERYFINDIT.COM )., As part ... surgeons with a wealth of peer-reviewed, practical ...
... 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI ... device company, today announced the completion of U.S. ... track plug., "Our proprietary Bio-Seal product represents ... diagnose lung cancer," said Dr.,William Hunter, President and ...
Cached Biology Technology:NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 2NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 3NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 4SURGERYFINDIT.COM and Convera(R) Launch Vertical Search Site for Surgeons 2Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 2Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 3Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 4
Anti-human C5/C5b, Clone 568, Monoclonal Antibody...
Transcription factor Sp2. [Source:Uniprot/SWISSPROT;Acc:Q02086] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... to Asparagine synthetase ( Abpromise ... Antigen: ... in the C-terminus of Human ... Entrez GeneID: 440 ...
Biology Products: